ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -245.6% | – | – | |
| – | -27.6% | -2.0% | -34.8% | +46.5% | -1.6% | -0.5% | +1.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -20.0% | +187.5% | +106.5% | |
| – | -3.7% | +161.7% | -105.4% | – | – | – | -117.5% | – | -99.6% | -17,060.0% | – | |
| – | -71.0% | -45.0% | -36.4% | +585.7% | -100.0% | – | – | – | – | – | – | |
| – | -71.0% | -45.0% | -36.4% | +585.7% | – | +27.3% | +1,564.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | -104.8% | – | – | – | -600.0% | – | +157.0% | -123.6% | – | +275.0% | +758.9% | |
| – | – | – | – | – | – | – | – | -25.2% | -64.0% | +1,027.0% | +3,943.4% | |
| – | – | – | – | – | – | – | – | – | -245.6% | – | – |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.